➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Colorcon
Boehringer Ingelheim
Medtronic

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

GLUCOTROL XL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Glucotrol Xl, and what generic alternatives are available?

Glucotrol Xl is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in GLUCOTROL XL is glipizide. There are eighteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the glipizide profile page.

US ANDA Litigation and Generic Entry Outlook for Glucotrol Xl

A generic version of GLUCOTROL XL was approved as glipizide by MYLAN on May 10th, 1994.

  Start Trial

Drug patent expirations by year for GLUCOTROL XL
Drug Prices for GLUCOTROL XL

See drug prices for GLUCOTROL XL

Drug Sales Revenue Trends for GLUCOTROL XL

See drug sales revenues for GLUCOTROL XL

Recent Clinical Trials for GLUCOTROL XL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NovartisPhase 2
LanZhou UniversityN/A
Chinese Academy of SciencesN/A

See all GLUCOTROL XL clinical trials

Pharmacology for GLUCOTROL XL
Drug ClassSulfonylurea
Paragraph IV (Patent) Challenges for GLUCOTROL XL
Tradename Dosage Ingredient NDA Submissiondate
GLUCOTROL XL TABLET, EXTENDED RELEASE;ORAL glipizide 020329

US Patents and Regulatory Information for GLUCOTROL XL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-002 Apr 26, 1994 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GLUCOTROL XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994   Start Trial   Start Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999   Start Trial   Start Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994   Start Trial   Start Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
McKesson
Mallinckrodt
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.